Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-7364
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients ; volume:10 ; number:1 ; day:24 ; month:11 ; year:2016 ; pages:1-12 ; date:12.2016
Human genomics ; 10, Heft 1 (24.11.2016), 1-12, 12.2016
- Urheber
-
Maksemous, Neven
- Beteiligte Personen und Organisationen
-
Smith, Robert A.
Haupt, Larisa M.
Griffiths, Lyn R.
SpringerLink (Online service)
- DOI
-
10.1186/s40246-016-0093-z
- URN
-
urn:nbn:de:1111-2016121520614
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maksemous, Neven
- Smith, Robert A.
- Haupt, Larisa M.
- Griffiths, Lyn R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing
Next generation PIRL for surgery and bio-diagnostics
Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing
Next generation PIRL for surgery and bio-diagnostics
Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing